LEGN
NASDAQ
$23.21
Legend Biotech Corp (LEGN)
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in North America and internationally.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $55.63 (+139.68%)
Market Cap
$4.26B
Revenue 5Y CAGR
+70.27%
Free Cash Flow Yield
-5.55%
Beta (5Y)
0.49
Price Chart
Valuation
Market Cap$4.26B
Forward P/E149.25
P/S3.91
P/B5.13
Profitability
Total Revenue (TTM)$1.14B
Gross Profit (TTM)$626M
EBITDA-$181M
Profit Margin-17.8%
Operating Margin-16.3%
EPS-$1.36
Financial Health
Debt-to-Equity40.2%
Free Cash Flow Yield-5.55%
Growth & Risk
EPS 5Y CAGR-13.49%
Revenue 5Y CAGR+70.27%
FCF 5Y CAGR-1.10%
Beta (5Y)0.49
Sharpe Ratio-0.57